Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02648763 · ClinicalTrials.gov registry record
Staging Procedures to Diagnose Malignant Pleural Mesothelioma
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 33
- Enrollment target
NCT02648763: Clinical Trial study, sponsored by Mayo Clinic.
NCT02648763 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02648763 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the accuracy of participants imaging versus staging procedures. The investigators will consent subjects that are scheduled to undergo staging procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy, endobronchial ultrasound and laparoscopy) as part of their standard of care.
Primary Outcome
The staging imaging will be compared with the actual surgical staging procedure to evaluate the accuracy of the imaging.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2016-01-15 |
| Est. Completion | 2023-04-22 |
Why NCT02648763 stopped before completion
NCT02648763 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02648763 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02648763 about?
NCT02648763 is a clinical study titled "Staging Procedures to Diagnose Malignant Pleural Mesothelioma". The purpose of this study is to evaluate the accuracy of participants imaging versus staging procedures. The investigators will consent subjects that are scheduled to undergo staging procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy, endobronchial ultrasound ...
What is the current status of trial NCT02648763?
This trial is currently terminated. The enrollment target is 33 participants. The study started on 2016-01-15. Estimated completion is 2023-04-22.
Who is sponsoring clinical trial NCT02648763?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI